Franck is a marine biologist, entrepreneur, and innovator known for his pioneering work in developing oxygen-carrying molecules derived from marine worms. He is the founder of Hemarina, a biotechnology company specializing in oxygen therapeutics for medical and industrial applications.
Franck has developed a groundbreaking innovation that could be considered the "holy grail" of medicine. His research focuses on using hemoglobin from lugworms (Arenicola marina) to revolutionize areas like organ preservation, wound healing, oncology, blood substitutes; etc. Franck’s entrepreneurial success has been widely recognized, as he has received several awards, including the prestigious EY Entrepreneur of the Year award in France, acknowledging his outstanding achievements and impact in both the biotech and business sectors.
Franck bridges marine biology, cutting-edge medical technologies, and strategic applications in critical fields like defense, space exploration, and emergency response, offering innovative solutions to the challenges of tomorrow.
